Integrity, honesty and fairness are the basics of any “ethical” corporate conduct and in the pharmaceutical industry in particular.

This ethical course of action is the driving principle in all the fields where we operate: from protecting a patient’s fundamental rights to ensuring transparency for our Research and Development processes, from manufacturing drugs to engaging relations with the scientific community; from respecting the environment to promoting social responsibility projects for the communities we operate in.

These fundamental principles are tied to two key documents we have enforced.


We believe it is important to ensure fairness and transparency in our pursuit of business as a way to protect the Group’s position and image and the work of our employees. For such reason, we have adopted an organisation, management and control model in accordance with the provisions of Legislative Decree No. 231 of 8th June 2001 (“Model 231”), which has introduced the concept of administrative liability for companies for some specific types of crime in the Italian law.

We have adopted and implemented our own Model 231 by taking into account – in addition to the provisions of the above Legislative Decree – the industry guidelines developed by Farmindustria (the Italian Pharmaceutical Industry association) and the specific initiatives we have already implemented with regard to internal control and corporate governance. The document is a behavioural paradigm of reference for anyone working on behalf of the companies of our Group and represents a step forward towards transparency and accountability both within the company and with the outside world, in order to offer the best guarantees of an efficient and proper form of management.

We have entrusted the task of supervising the enforcement of, and the compliance with, the Model 231 and ensuring it is regularly updated to a special supervisory body. A specific email address is in place for any related submission:


An integral part of Model 231 is our own Code of Conduct, which we have developed to give shape and substance to the culture of accountability and integrity that is deeply rooted in our company.

Compliance with laws, professional ethics and procedures is the foundation of our Code of Conduct, which strictly and simply expresses the principles underpinning our relationships with all stakeholders, as well as our commitment to ensure health and safety are safeguarded and the needs and expectations of patients, the scientific community and the public in general are met. Such principles are meant to always guide our behaviours wherever we operate, either in Italy or abroad.

We have always acted and built relationships by expressing our distinctive identity, which is based on the culture, history and set of values that make us instantly recognizable to our audience. Our Code of Conduct is a document of accountability with respect to the communities where we operate and it is meant to protect and strengthen our values, of which it is an integral and core part.

Dompé farmaceutici S.p.A. Single shareholder company / Share capital € 50.000.000,00
REA MI 289519 - A registered company in Milan, Italy / Tax code and VAT number IT00791570153